Terumo Corporation

Japanese medical device company specializing in cardiovascular and blood management

Healthtech & BiotechTokyo, JapanEast AsiaAdvantage marketLatest Mar 12, 2026
Monitoring Status
Signals (30d)
1
Most active type
Product Launch
Primary channel
Healthtech & Biotech
Primary theme
Healthtech & Biotech
Latest update
Mar 12, 2026
vs. prior 30 days
Rising

Key Changes (30d)

Mar 20Verified

Terumo launches VenoJect II RAPClot blood collection tubes in Japan in partnership with Q-Sera

Terumo Corporation launches VenoJect II RAPClot blood collection tubes in Japan, integrating Q-Sera's technology to accelerate blood clotting for faster diagnostics.

Source Language Distribution

Language distribution will appear as more signals are collected from diverse sources.

Strategic themes and signal pattern

Strategic Themes

MedTechCardiovascular

Recent Signal Pattern

Most frequent signal typeProduct Launch
Activity Trend (30d)
Rising
0
1
Prev 30dLast 30d
Sources tracked5
Total signals tracked2

Why this company matters

Tokopedia is a critical company to monitor for insights into the competitive landscape of Southeast Asian e-commerce, particularly the battle for dominance in the massive Indonesian market. Its recent acquisition by ByteDance makes it a key case study for the convergence of social media and e-commerce, providing signals on the strategic maneuvers of tech giants like GoTo, Sea Ltd., and ByteDance as they compete for digital supremacy.

Channel Context

Healthtech & Biotech

Terumo Corporation is a key company within the Healthtech & Biotech channel. Its official updates regularly contribute to how users track developments in this space.

View channel

Market Context

This company operates in one of SigFact's strongest advantage markets, where official updates often surface first in local language.

See recent signals in this market

Continue monitoring Terumo Corporation

Follow this company, add it to your watchlist, or explore its signal stream to stay informed.

Add to Watchlist